Quantum BioPharma Ltd.
QNTM
$18.09
$0.0350.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.89% | -60.00% | -40.06% | -22.99% | -63.49% |
| Total Depreciation and Amortization | 9.02% | 14.98% | -6.62% | -11.70% | 13.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.11% | 231.90% | -693.78% | -947.05% | -87.98% |
| Change in Net Operating Assets | -480.93% | -96.14% | 1,092.19% | -73.41% | 517.87% |
| Cash from Operations | 54.26% | -409.79% | 75.85% | -470.62% | 69.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.82% | -208.55% | 135.91% | -569.18% | 3,440.27% |
| Cash from Investing | -0.82% | -208.55% | 135.91% | -569.18% | 3,440.27% |
| Total Debt Issued | -36.90% | 207.46% | 434.15% | -2,004.40% | -94.46% |
| Total Debt Repaid | -3,415.45% | 21.81% | -547.83% | 68.49% | 0.68% |
| Issuance of Common Stock | 217.86% | -96.91% | -78.92% | 282.19% | 521.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -58.84% | 26.99% | -63.38% | 265.26% | 224.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.44% | -186.16% | 1,642.70% | -109.43% | 238.52% |